Key circRNA Identification of Postoperative Delirium in Elderly Patients Undergoing Cardiac Surgery
NCT ID: NCT05743660
Last Updated: 2023-03-07
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
50 participants
OBSERVATIONAL
2022-06-30
2023-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Whether there are changes in circRNA expression in peripheral blood in elderly patients with delirium after cardiopulmonary bypass surgery? Whether the circRNA with altered expression plays an important role in the occurrence and development of POD? What are the functions and underlying mechanisms of circRNA with altered expression in POD? Voluntary patients will receive follow-up 1 day before and 7 days after surgery to assess their cognitive function, and peripheral blood will be collected 1 day before and 3 days after surgery. The study divided patients into POD group and non-POD group according to whether delirium occurred within 7 days after surgery.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Study on Biomarkers of Postoperative Delirium in Elderly Cardiac Surgery Patients
NCT06194474
Postoperative Delirium in Patients Undergoing Cardiac Surgery
NCT07239648
Postoperative Delirium and Its Biomarkers in Elderly Patients Undergoing Non-cardiac and Non-neurosurgery.
NCT05177159
Sleep and Circadian Rhythm Biomarkers of Postoperative Delirium
NCT06052397
Study of Postoperative Delirium in Elderly People After Orthopedic Surgery
NCT02817386
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
POD group
According to the occurrence of postoperative delirium, the patients were divided into POD group and non-POD group
No interventions assigned to this group
non-POD group
According to the occurrence of postoperative delirium, the patients were divided into POD group and non-POD group
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. ASA Grade I-III;
3. Heart surgery is planned under general anesthesia.
Exclusion Criteria
2. The ejection fraction is less than 40%;
3. The score of the preoperative simple mental status examination (MMSE) is less than 24 points;
4. Patients with mental illness or central nervous system disease;
5. Patients who cannot or refuse to complete MMSE before surgery.
50 Years
90 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Xuzhou Central Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Yangzi Zhu, Doctor
Role: PRINCIPAL_INVESTIGATOR
Xuzhou Central Hospital
Liwei Wang, Doctor
Role: STUDY_DIRECTOR
Xuzhou Central Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Xuzhou Central Hospital
Xuzhou, Jiangsu, China
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
XuzhouCH20220629
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.